Latest News for: vb10

Edit

Nykode Therapeutics Strengthens Intellectual Property Portfolio with New U.S. Patent for the Neoantigen Selection Method for VB10.NEO, Nykode’s Individualized Neoantigen Therapy (Nykode Therapeutics AS)

Public Technologies 04 Nov 2025
Nykode is positioning VB10.NEO as a leading individualized neoantigen therapy, ... individualized neoantigen-based therapy, VB10.NEO ... individualized neoantigen therapy VB10.NEO ... About VB10.NEO. VB10.NEO is a ...
  • 1

Article Search

tools
×
×
×
×